Aqr Capital Management LLC G1 Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $497,360 - $634,842	-202,179 Reduced 72.96%	74,927 $186,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $712,162 - $2.26 Million	277,106 New	277,106 $742,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $435,201 - $656,828	-21,188 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $482,662 - $859,809	21,188 New	21,188 $483,000
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $311,735 - $604,801	-19,447 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$14.4 - $21.45 $187,603 - $279,450	-13,028 Reduced 40.12%	19,447 $323,000
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $221,630 - $689,053	13,424 Added 70.46%	32,475 $622,000
Q3 2018 Nov 15, 2018	BUY	$43.15 - $67.97 $361,640 - $569,656	8,381 Added 78.55%	19,051 $996,000
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $374,090 - $545,983	10,670 New	10,670 $464,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.